General Information of Drug (ID: DMLQK6E)

Drug Name
PYM-50028 Drug Info
Synonyms Cogane; Smilagenin; P-58; P-63
Cross-matching ID
TTD Drug ID
D0M2TG

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 2.29 0.00e+0 34/36 (94.44%) FEN1;POLE2;PCNA;...
Base excision repair 1.84 3.33e-2 29/33 (87.88%) FEN1;POLE2;PCNA;...
Osteoclast differentiation -1.62 3.83e-2 117/127 (92.13%) MAPK11;PLCG2;TNFRSF11A;...
Cell adhesion molecules -1.62 3.87e-2 118/148 (79.73%) PDCD1LG2;ITGAV;CD6;...
Salmonella infection -1.66 3.70e-2 198/249 (79.52%) EXOC5;BAX;ARPC2;...
Chemokine signaling pathway -1.67 3.42e-2 163/192 (84.9%) ADCY2;WAS;NFKBIB;...
Bladder cancer -1.68 3.22e-2 40/41 (97.56%) HRAS;CDK4;RB1;...
Lysosome -1.68 3.25e-2 115/128 (89.84%) CTSB;LAMP1;ATP6V1H;...
Phagosome -1.70 2.98e-2 118/152 (77.63%) ITGAV;ATP6V1F;HGS;...
Legionellosis -1.70 2.95e-2 51/57 (89.47%) HSPA2;HSPA6;HSPD1;...
B cell receptor signaling pathway -1.73 2.58e-2 71/81 (87.65%) LILRA5;GSK3B;CD19;...
Apoptosis -1.77 1.76e-2 126/168 (75%) PIK3CD;TRADD;ATM;...
Colorectal cancer -1.77 1.79e-2 84/86 (97.67%) SMAD4;BCL2L11;RAC2;...
Tyrosine metabolism -1.77 1.88e-2 30/36 (83.33%) ALDH3B1;ADH1A;ADH6;...
Pentose and glucuronate interconversions -1.77 1.92e-2 17/34 (50%) CRYL1;UGT2B17;UGT2B15;...
Lipid and atherosclerosis -1.81 1.23e-2 190/215 (88.37%) ATF6;BAX;IKBKG;...
NOD-like receptor signaling pathway -1.82 1.16e-2 145/181 (80.11%) CTSB;NFKBIB;PSTPIP1;...
Autoimmune thyroid disease -1.84 9.04e-3 46/53 (86.79%) HLA-A;HLA-DOA;HLA-DQA1;...
Fluid shear stress and atherosclerosis -1.87 6.16e-3 123/139 (88.49%) NFE2L2;GSTM5;PIK3CD;...
Intestinal immune network for IgA production -1.91 1.90e-3 38/48 (79.17%) HLA-DOA;HLA-DQA1;HLA-DQB1;...
Primary bile acid biosynthesis -1.92 2.05e-3 15/17 (88.24%) CYP27A1;SLC27A5;CH25H;...
Antigen processing and presentation -1.93 2.24e-3 60/78 (76.92%) CTSB;HLA-A;TAP1;...
Graft-versus-host disease -1.96 1.23e-3 32/42 (76.19%) HLA-A;HLA-DOA;HLA-DQA1;...
Viral protein interaction with cytokine and cytokine re... -1.99 1.37e-3 84/100 (84%) CXCR2;CXCL13;CCL19;...
NF-kappa B signaling pathway -2.06 1.54e-3 90/104 (86.54%) TLR4;PIDD1;CSNK2A1;...
Steroid biosynthesis -2.06 1.76e-3 19/20 (95%) FDFT1;DHCR7;EBP;...
Type I diabetes mellitus -2.11 0.00e+0 38/43 (88.37%) HLA-A;HLA-DOA;HLA-DQA1;...
Epithelial cell signaling in Helicobacter pylori infect... -2.13 0.00e+0 62/70 (88.57%) ATP6V1F;ATP6V1H;GIT1;...
TNF signaling pathway -2.24 0.00e+0 103/112 (91.96%) NFKB1;ATF4;CASP10;...
Allograft rejection -2.27 0.00e+0 32/38 (84.21%) CD80;CD40LG;HLA-A;...
IL-17 signaling pathway -2.41 0.00e+0 84/94 (89.36%) ELAVL1;MAPK14;IFNG;...
Rheumatoid arthritis -2.41 0.00e+0 78/93 (83.87%) HLA-DOA;HLA-DQA1;HLA-DQB1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.004uM - 4uM 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.004uM - 4uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.004uM - 4uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.004uM - 4uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.004uM - 4uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.004uM - 4uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.004uM - 4uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.004uM - 4uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.004uM - 4uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.004uM - 4uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.004uM - 4uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.004uM - 4uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.004uM - 4uM 24H